Why the study?
Does blood pressure lowering therapy reduce major cardiovascular events differently in younger (<65 years) versus older (≥65 years) adults?
Population
190,606 participants from 31 randomized trials, analyzed by age groups (<65 vs ≥65 years)
Comparison
Different regimens and drug classes to lower… vs Compared across age groups (<65 vs ≥65 years)
Design
Meta-analysis
Loading...
Supports BP lowering for CV prevention across adult ages; reinforces uniform relative efficacy independent of age.
Does blood pressure lowering therapy reduce major cardiovascular events differently in younger (<65 years) versus older (≥65 years) adults?
Blood pressure lowering provides similar relative protection against major cardiovascular events in both younger and older adults, regardless of the drug class used.
A 2008 study studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: